Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/124905COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE 2 in colorectal cancer |
Autor: | Cebola, Inês; Prieto, Patricia CSIC ORCID; Boscá, Lisardo CSIC ORCID CVN ; Moreno, Víctor; Peinado, Miguel A. | Fecha de publicación: | 2015 | Editor: | BioMed Central | Citación: | Clinical Epigenetics 7: 74 (2015) | Resumen: | [Background]: Misregulation of the PTGS (prostaglandin endoperoxide synthase, also known as cyclooxygenase or COX) pathway may lead to the accumulation of pro-inflammatory signals, which constitutes a hallmark of cancer. To get insight into the role of this signaling pathway in colorectal cancer (CRC), we have characterized the transcriptional and epigenetic landscapes of the PTGS pathway genes in normal and cancer cells. [Results]: Data from four independent series of CRC patients (502 tumors including adenomas and carcinomas and 222 adjacent normal tissues) and two series of colon mucosae from 69 healthy donors have been included in the study. Gene expression was analyzed by real-time PCR and Affymetrix U219 arrays. DNA methylation was analyzed by bisulfite sequencing, dissociation curves, and HumanMethylation450K arrays. Most CRC patients show selective transcriptional deregulation of the enzymes involved in the synthesis of prostanoids and their receptors in both tumor and its adjacent mucosa. DNA methylation alterations exclusively affect the tumor tissue (both adenomas and carcinomas), redirecting the transcriptional deregulation to activation of prostaglandin E 2 (PGE 2 ) function and blockade of other biologically active prostaglandins. In particular, PTGIS, PTGER3, PTGFR, and AKR1B1 were hypermethylated in more than 40 % of all analyzed tumors. [Conclusions]: The transcriptional and epigenetic profiling of the PTGS pathway provides important clues on the biology of the tumor and its microenvironment. This analysis renders candidate markers with potential clinical applicability in risk assessment and early diagnosis and for the design of new therapeutic strategies. | Descripción: | This is an Open Access article distributed under the terms of the Creative Commons Attribution License.-- et al. | Versión del editor: | http://dx.doi.org/10.1186/s13148-015-0110-4 | URI: | http://hdl.handle.net/10261/124905 | DOI: | 10.1186/s13148-015-0110-4 | Identificadores: | doi: 10.1186/s13148-015-0110-4 issn: 1868-7075 e-issn: 1868-7083 |
| Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Epigenetics override.pdf | 2,62 MB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
31
checked on 17-abr-2024
SCOPUSTM
Citations
34
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
32
checked on 27-feb-2024
Page view(s)
313
checked on 23-abr-2024
Download(s)
258
checked on 23-abr-2024
